These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 30594176)
21. The efficacy of combination therapy using adeno-associated virus-TRAIL targeting to telomerase activity and cisplatin in a mice model of hepatocellular carcinoma. Wang Y; Huang F; Cai H; Wu Y; He G; Tan WS J Cancer Res Clin Oncol; 2010 Dec; 136(12):1827-37. PubMed ID: 20213096 [TBL] [Abstract][Full Text] [Related]
22. Lipocalin 2 Enhances Migration and Resistance against Cisplatin in Endometrial Carcinoma Cells. Miyamoto T; Kashima H; Yamada Y; Kobara H; Asaka R; Ando H; Higuchi S; Ida K; Mvunta DH; Shiozawa T PLoS One; 2016; 11(5):e0155220. PubMed ID: 27168162 [TBL] [Abstract][Full Text] [Related]
23. A novel antitumor piperazine alkyl compound causes apoptosis by inducing RhoB expression via ROS‑mediated c‑Abl/p38 MAPK signaling. Chung KS; Han G; Kim BK; Kim HM; Yang JS; Ahn J; Lee K; Song KB; Won M Cancer Chemother Pharmacol; 2013 Dec; 72(6):1315-24. PubMed ID: 24121479 [TBL] [Abstract][Full Text] [Related]
24. The antitumor effect of lobaplatin against Ishikawa endometrial cancer cells in vitro and in vivo. He J; Zhang H Biomed Pharmacother; 2019 Jun; 114():108762. PubMed ID: 30925454 [TBL] [Abstract][Full Text] [Related]
25. Cisplatin increases B-cell-lymphoma-2 expression via activation of protein kinase C and Akt2 in endometrial cancer cells. Rouette A; Parent S; Girouard J; Leblanc V; Asselin E Int J Cancer; 2012 Apr; 130(8):1755-67. PubMed ID: 21618512 [TBL] [Abstract][Full Text] [Related]
26. [Overexpression of leukemia inhibitory factor enhances chemotherapy tolerance of endometrial cancer cells Ruan X; Zhong M; Liu W; Liu Q; Lu W; Zheng Y; Zhang X Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jan; 40(1):20-26. PubMed ID: 32376564 [TBL] [Abstract][Full Text] [Related]
27. Estrogen enhances mismatch repair by induction of MLH1 expression via estrogen receptor-β. Lu JY; Jin P; Gao W; Wang DZ; Sheng JQ Oncotarget; 2017 Jun; 8(24):38767-38779. PubMed ID: 28404976 [TBL] [Abstract][Full Text] [Related]
28. PGK1 facilities cisplatin chemoresistance by triggering HSP90/ERK pathway mediated DNA repair and methylation in endometrial endometrioid adenocarcinoma. Zhou JW; Tang JJ; Sun W; Wang H Mol Med; 2019 Mar; 25(1):11. PubMed ID: 30925862 [TBL] [Abstract][Full Text] [Related]
29. Emodin Enhances the Chemosensitivity of Endometrial Cancer by Inhibiting ROS-Mediated Cisplatin-resistance. Ding N; Zhang H; Su S; Ding Y; Yu X; Tang Y; Wang Q; Liu P Anticancer Agents Med Chem; 2018; 18(7):1054-1063. PubMed ID: 29256357 [TBL] [Abstract][Full Text] [Related]
30. Noscapine Increases the Sensitivity of Drug-Resistant Ovarian Cancer Cell Line SKOV3/DDP to Cisplatin by Regulating Cell Cycle and Activating Apoptotic Pathways. Shen W; Liang B; Yin J; Li X; Cheng J Cell Biochem Biophys; 2015 May; 72(1):203-13. PubMed ID: 25510462 [TBL] [Abstract][Full Text] [Related]
31. Enhanced antitumor activity by combining an adenovirus harboring ING4 with cisplatin for hepatocarcinoma cells. Xie Y; Sheng W; Miao J; Xiang J; Yang J Cancer Gene Ther; 2011 Mar; 18(3):176-88. PubMed ID: 21052098 [TBL] [Abstract][Full Text] [Related]
32. PEA‑15 contributes to the clinicopathology and AKT‑regulated cisplatin resistance in gastric cancer. Jiang X; Zhang C; Li W; Jiang D; Wei Z; Lv M; Xie X; Sun X Oncol Rep; 2019 Mar; 41(3):1949-1959. PubMed ID: 30569123 [TBL] [Abstract][Full Text] [Related]
33. [Adenovirus-delivered tissue inhibitor of metalloproteinases-3 transfection increases the sensitivity of cervical cancer cells to cisplatin]. Zhang Y; Lin C; Qian HL; Lang JH; Fu M; Zhang XY; Liang X; Duan H; Xiang Y Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):25-9. PubMed ID: 17575689 [TBL] [Abstract][Full Text] [Related]
34. Sam68 reduces cisplatin-induced apoptosis in tongue carcinoma. Chen S; Li H; Zhuang S; Zhang J; Gao F; Wang X; Chen W; Song M J Exp Clin Cancer Res; 2016 Jul; 35(1):123. PubMed ID: 27473117 [TBL] [Abstract][Full Text] [Related]
35. Knockdown of Bmi1 inhibits bladder cancer cell growth both in vitro and in vivo by blocking cell cycle at G1 phase and inducing apoptosis. Luo HB; Li B; Yuan WG; Xu CR J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):730-735. PubMed ID: 26489630 [TBL] [Abstract][Full Text] [Related]
36. Growth inhibition and chemo-radiosensitization of head and neck squamous cell carcinoma (HNSCC) by survivin-siRNA lentivirus. Khan Z; Khan AA; Prasad GB; Khan N; Tiwari RP; Bisen PS Radiother Oncol; 2016 Feb; 118(2):359-68. PubMed ID: 26747757 [TBL] [Abstract][Full Text] [Related]
37. Rapamycin enhanced the antitumor efficacy of oxaliplatin in cisplatin-resistant ovarian cancer cells A2780cis both in vitro and in vivo. Liu J; Zhang L; Zhang X; Xing X J Chemother; 2015; 27(6):358-64. PubMed ID: 25976336 [TBL] [Abstract][Full Text] [Related]
38. Combination DLL4 with Jagged1-siRNA can enhance inhibition of the proliferation and invasiveness activity of human gastric carcinoma by Notch1/VEGF pathway. Sun HW; Wu C; Tan HY; Wang QS Hepatogastroenterology; 2012 May; 59(115):924-9. PubMed ID: 22020917 [TBL] [Abstract][Full Text] [Related]
39. Effect of cyclin-dependent kinase 7 silencing on cisplatin sensitivity in endometrial carcinoma cells. Liu WX; Liu XY; Yu H; Chen Y; Hao Q Mol Med Rep; 2015 Mar; 11(3):1745-51. PubMed ID: 25411854 [TBL] [Abstract][Full Text] [Related]
40. Extracellular vesicles transmitted miR-31-5p promotes sorafenib resistance by targeting MLH1 in renal cell carcinoma. He J; He J; Min L; He Y; Guan H; Wang J; Peng X Int J Cancer; 2020 Feb; 146(4):1052-1063. PubMed ID: 31259424 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]